AR015485A1 - Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag - Google Patents

Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag

Info

Publication number
AR015485A1
AR015485A1 ARP980105880A ARP980105880A AR015485A1 AR 015485 A1 AR015485 A1 AR 015485A1 AR P980105880 A ARP980105880 A AR P980105880A AR P980105880 A ARP980105880 A AR P980105880A AR 015485 A1 AR015485 A1 AR 015485A1
Authority
AR
Argentina
Prior art keywords
paroxetine
formulation
solid
vehicle
dissolved
Prior art date
Application number
ARP980105880A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR015485A1 publication Critical patent/AR015485A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP980105880A 1997-11-21 1998-11-19 Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag AR015485A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation

Publications (1)

Publication Number Publication Date
AR015485A1 true AR015485A1 (es) 2001-05-02

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105880A AR015485A1 (es) 1997-11-21 1998-11-19 Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag

Country Status (24)

Country Link
EP (1) EP1033986A1 (no)
JP (1) JP2001523718A (no)
KR (1) KR20010032320A (no)
CN (1) CN1279608A (no)
AP (1) AP2000001821A0 (no)
AR (1) AR015485A1 (no)
AU (1) AU1168099A (no)
BG (1) BG104527A (no)
BR (1) BR9814220A (no)
CO (1) CO4970832A1 (no)
DZ (1) DZ2658A1 (no)
EA (1) EA200000552A1 (no)
GB (1) GB9724544D0 (no)
HU (1) HUP0100580A3 (no)
IL (1) IL136106A0 (no)
MA (1) MA24704A1 (no)
NO (1) NO20002590L (no)
OA (1) OA11385A (no)
PE (1) PE20000381A1 (no)
PL (1) PL340555A1 (no)
SK (1) SK7342000A3 (no)
TR (1) TR200001423T2 (no)
WO (1) WO1999026625A1 (no)
ZA (1) ZA9810637B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
ATE248165T1 (de) 1999-07-01 2003-09-15 Italfarmaco Spa Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
DE60222803T2 (de) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. Orale kapselformulierung mit verbesserter physikalischer stabilität
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
WO2011071194A1 (ko) * 2009-12-08 2011-06-16 주식회사 일화 20-O-β-D-글루코피라노실-20(S)-프로토파낙사디올을 포함하는 고체분산체
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
KR20000070151A (ko) * 1997-01-15 2000-11-25 피터 기딩스 파록세틴 조성물

Also Published As

Publication number Publication date
DZ2658A1 (fr) 2003-03-22
BG104527A (en) 2001-04-30
HUP0100580A3 (en) 2002-05-28
EP1033986A1 (en) 2000-09-13
ZA9810637B (en) 2000-05-22
CN1279608A (zh) 2001-01-10
WO1999026625A1 (en) 1999-06-03
KR20010032320A (ko) 2001-04-16
TR200001423T2 (tr) 2000-10-23
NO20002590L (no) 2000-07-19
EA200000552A1 (ru) 2000-10-30
IL136106A0 (en) 2001-05-20
AP2000001821A0 (en) 2000-06-30
MA24704A1 (fr) 1999-07-01
CO4970832A1 (es) 2000-11-07
SK7342000A3 (en) 2000-12-11
JP2001523718A (ja) 2001-11-27
NO20002590D0 (no) 2000-05-19
AU1168099A (en) 1999-06-15
BR9814220A (pt) 2001-12-26
HUP0100580A2 (hu) 2002-04-29
GB9724544D0 (en) 1998-01-21
OA11385A (en) 2004-01-27
PL340555A1 (en) 2001-02-12
PE20000381A1 (es) 2000-05-07

Similar Documents

Publication Publication Date Title
JP7501926B2 (ja) 特定の胃腸部位での制御放出の剤形
AR015485A1 (es) Una capsula oral tragable que contiene paroxetina, una forma solida de dosificacion oral tragable, una formulacion farmaceutica, una procedimiento parapreparar dicha formulacion y la utilizacion de paroxetina disuelta en un vehiculo para fabricar capsulas o formas solidas de dosificacion orales trag
ES2593047T3 (es) Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
US20030104048A1 (en) Pharmaceutical dosage forms for highly hydrophilic materials
BR9916224A (pt) Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola
ES2164940T3 (es) Forma de dosificacion solida bioadhesiva.
AR006652A1 (es) Forma farmacéutica de dosificación oral para el tratamiento oral de enfermedades óseas.
RU2012102772A (ru) Фармацевтическая таблетка, содержащая заполненную жидкостью капсулу
ES2187822T3 (es) Comprimidos de disgregacion rapida.
CO4940409A1 (es) Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior
JP7261830B2 (ja) 剤形およびそれらの使用
ECSP034826A (es) Método para fabricar una composición farmacéutica de dosis baja
CN105142596A (zh) 用于治疗口腔干燥和用于牙齿治疗的组合物
Cocoș et al. Challenges in Optimizing Nanoplatforms Used for Local and Systemic Delivery in the Oral Cavity
BR0210224A (pt) Formas de dosagem projetada para ser engolida diretamente e apresentada como uma formulação em comprimido ou cápsula deglutìvel, e, processo para preparação de uma forma de dosagem
MXPA06008241A (es) Composicion dermatologica de gel suave.
BR0115989A (pt) Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido
JPH02157220A (ja) 徐放性坐剤
AR013261A1 (es) Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina
HUT62471A (en) Process for producing pharmaceutical compositions comprising ipriflavone
ES2935528T3 (es) Formulación y suspensión oral de un fármaco oncológico
ES2286998T3 (es) Formulacion estable que contiene fumagillina.
DE60331920D1 (de) Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
AR033331A1 (es) Formas polimorfas de un citrato de azabiciclo [2,2,2] octan-3-amina, sus composiciones farmaceuticas, procedimiento de tratamiento y procedimiento para su produccion.
HN1999000174A (es) Formulacion medicamentosa acuisa para administracion oral.